Gene fusion neoantigens: Emerging targets for cancer immunotherapy
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference63 articles.
1. The future of immune checkpoint therapy;Sharma;Science,2015
2. An immunogenic personal neoantigen vaccine for patients with melanoma;Ott;Nature,2017
3. Adoptive cell transfer as personalized immunotherapy for human cancer;Rosenberg;Science,2015
4. Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy;Coulie;Nat Rev Cancer,2014
5. Neoantigens in cancer immunotherapy;Schumacher;Science,2015
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PRKCSH serves as a potential immunological and prognostic biomarker in pan-cancer;Scientific Reports;2024-01-20
2. An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects;Life Sciences;2024-01
3. Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities;Cell Genomics;2024-01
4. Therapeutic cancer vaccines: advancements, challenges, and prospects;Signal Transduction and Targeted Therapy;2023-12-13
5. Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer;Nature Communications;2023-11-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3